Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03748264 · ClinicalTrials.gov registry record · NA
User Preference/Validation Evaluation of the New Philips Respironics Positive Airway Pressure Application
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT03748264: Completed NA study, sponsored by Philips Respironics.
NCT03748264 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03748264, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This pilot study is intended to evaluate the acceptance and performance of the DreamMapper application and the Therapist Assist educational tool in naïve patients with Obstructive Sleep Apnea who have been prescribed Positive Airway Pressure therapy. A total of approximately 60 naïve participants will be recruited.
Primary Outcome
Participants will complete the Attitudes Toward Use Questionnaire (0 to 10 scale) to determine user preference of the New Philips Respironics Positive Airway Pressure Application. The higher the value the higher participant confidence.
Interventions
- OTHER Standard of Care
- DEVICE DreamMapper Application
- DEVICE DreamMapper Application with Therapist Assist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2013-10-21 |
| Est. Completion | 2014-05-27 |
| Phase | NA |
What the finished NCT03748264 record still lists
NCT03748264 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard of Care is the first listed.
NCT03748264 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03748264 about?
NCT03748264 is a clinical study titled "User Preference/Validation Evaluation of the New Philips Respironics Positive Airway Pressure Application". This pilot study is intended to evaluate the acceptance and performance of the DreamMapper application and the Therapist Assist educational tool in naïve patients with Obstructive Sleep Apnea who have been prescribed Positive Airway Pressure therapy. A total of approximately 60 naïve participants wi...
What is the current status of trial NCT03748264?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2013-10-21. Estimated completion is 2014-05-27.
What interventions are being tested in trial NCT03748264?
The interventions under investigation include: Standard of Care (OTHER), DreamMapper Application (DEVICE), DreamMapper Application with Therapist Assist (DEVICE).
Who is sponsoring clinical trial NCT03748264?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03748264's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI